Developing new methods for creating important chemical compounds.
Innovative Tools for Chemical Synthesis: Metal-Hydride Catalysis, Medicinal Motifs, and Molecular Probes
This study is exploring new ways to create important molecules that can help in developing better treatments for diseases like cancer, using common building blocks and special techniques to make the process more efficient.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11167029 on NIH RePORTER |
What this research studies
This research focuses on advancing innovative catalytic methods to synthesize complex molecules that are crucial for various scientific fields, particularly in drug discovery. By utilizing common functional groups, the project aims to create new carbon-carbon and carbon-nitrogen bonds with high efficiency. The research involves both experimental and theoretical approaches to understand the mechanisms of transition metal catalysts and to design functional molecules that can aid in cancer immunotherapy and other applications. Collaborations with experts in microscopy and spectroscopy will enhance the practical applications of these synthesized compounds.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new pharmaceutical compounds developed through this innovative synthesis.
Not a fit: Patients who are not seeking new treatment options or those with conditions unrelated to the compounds being synthesized may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new drugs and therapies that improve patient outcomes in various diseases.
How similar studies have performed: Other research in the field of organic synthesis and catalysis has shown significant success, indicating that this approach has the potential for impactful advancements.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Dong, Vy M — University of California-Irvine
- Study coordinator: Dong, Vy M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.